How deadly is Breast cancer?

['Denggem daytoy a panid']

Kasano kasaknap ti makapapatay a kanser ti suso?

Ti kanser ti suso ket maysa a nakaro ken mabalin a makapapatay a sakit.

Dayta ti kadawyan a kanser kadagiti babbai iti intero a lubong ken ti maikadua a kangrunaan a pakaigapuan ti ipapatay dagiti babbai gapu iti kanser.

Sigun iti American Cancer Society, idi 20220, mapattapatta a 276,480 a baro a kaso ti invasive breast cancer ti nadayagnos kadagiti babbai idiay Estados Unidos, ket agarup 42,170 a babbai idiay E.U. ti natay gapu iti breast cancer.

Nupay kasta, bimmassit ti bilang dagiti matmatay iti kanser ti suso sipud idi 1989, a bimmassit iti 40% manipud 1989 agingga iti 2017, nangruna gapu iti simmayaatan ti nasapa a panangilasin ken panangagas.

Ti peggad iti ipapatay iti kanser ti suso agduduma depende kadagiti banag a kas iti edad, kasasaad ti kanser iti suso idi nadayagnos, ken ti kita ti kanser iti suso.

Ti nasapa a panangilasin ken panangagas ket dakkel ti maitulongna tapno makalasat ti maysa.

['Dagiti reperensia']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL: Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer. 2011, 104 (6): 910-4.

DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL: Breast cancer statistics, 2019. CA Cancer J Clin. 2019, 69 (6): 438-451.

Icaza G, Núñez L, Bugueño H: [Epidemiological analysis of breast cancer mortality in women in Chile]. Rev Med Chil. 2017, 145 (1): 106-114.

Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles EA: Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging. J Am Coll Radiol. 2017, 14 (9): 1137-1143.

Deaths from breast cancer--United States, 1991. MMWR Morb Mortal Wkly Rep. 1994, 43 (15): 273, 279-81.

Kuroishi T, Hirose K, Suzuki T, Tominaga S: Effectiveness of mass screening for breast cancer in Japan. Breast Cancer. 2000, 7 (1): 1-8.

['Disclaimer: medikal']

['Daytoy a website ket maipaay laeng a pangisuro ken pakaammuan ken saan a mangipaay iti medikal a balakad wenno propesional a serbisio.']

['Ti naited nga impormasion ket saan a rumbeng a mausar a pangdayagnos wenno pangagas iti sakit, ket dagidiay agbirbirok iti personal a medikal a balakad rumbeng nga agkonsultada iti lisensiado a doktor.']

['Pangngaasiyo ta laglagipenyo a ti neural net a mangpataud kadagiti sungbat kadagiti saludsod ket saan a husto no maipapan iti numeriko a linaon. Kas pagarigan, ti bilang dagiti tattao a nadayagnos nga addaan iti espesipiko a sakit.']

['Kanayon nga agpabalakadka iti doktormo wenno iti sabali a kualipikado a mangay-aywan iti salun-at maipapan iti kasasaadmo. Dimo pulos baybay-an ti propesional a balakad ti doktor wenno itantan ti agpabalakad gapu iti nabasam iti daytoy a website. No ipagarupmo nga adda emerhensia a kasapulam, tumawagka iti 911 wenno mapanka a dagus iti kaasitgan nga emergency room. Awan ti relasion ti doktor ken pasiente gapu iti daytoy a website wenno ti panangusar iti dayta. Saan a mangirepresentar ti BioMedLib wenno dagiti empleadona, wenno ti asinoman a tumultulong iti daytoy a website, iti aniaman a direkta wenno saan a direkta, mainaig iti impormasion a naited ditoy wenno iti pannakausarna.']

['Disclaimer: karbengan ti kopia']

['Ti Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (ti DMCA) mangipaay iti pamuspusan para kadagiti makinkukua iti copyright a mamati a ti material a makita iti Internet salungasingenna dagiti kalinteganda iti sidong ti linteg ti copyright ti E.U. ']

['No patiem a naimbag ti nakemmo a ti aniaman a linaon wenno material a naikabil mainaig iti website wenno serbisiotayo salungasingenna ti copyright-mo, mabalinmo (wenno ti ahentem) ti mangipaima kadakami iti pakaammo a mangkiddaw a maikkat ti linaon wenno material, wenno malapdan ti panagusar iti dayta. ']

['Dagiti pakaammo masapul a maipatulod iti surat babaen ti e-mail (kitaen ti benneg a "Kontak" para iti e-mail address). ']

['Kalikaguman ti DMCA a ti pakaammoyo iti maipagarup a panaglabsing iti copyright ramanenna dagiti sumaganad nga impormasion: (1) deskripsion ti copyrighted a trabaho a suheto ti maipagarup a panaglabsing; (2) deskripsion ti maipagarup a linaon a manglabsing ken impormasion nga umdas a mangipalubos kadakami a mangbirok iti linaon; (3) impormasion a pangkontakan kadakayo, agraman ti adresyo, numero ti telepono ken email address; (4) deklarasionyo a patienyo a ti linaon iti wagas a naireklamo ket saan nga impalubos ti akinkukua iti copyright, wenno ti ahentena, wenno babaen ti aniaman a linteg; ']

['(5) maysa a deklarasionyo, a pinirmaanyo iti sidong ti dusa a panagsaksi iti ulbod, a ti impormasion iti pakaammo ket umiso ken adda autoridadyo a mangipatungpal kadagiti copyright a makuna a nasalungasing; ']

['ken (6) pisikal wenno elektroniko a pirma ti makinkukua iti copyright wenno ti tao a napalubosan nga agtignay para iti makinkukua iti copyright. ']

['No saan a mairaman amin nga impormasion a nadakamat iti ngato, mabalin a maitantan ti pannakataming ti reklamoyo.']

['Kontak']

['Pangngaasiyo ta patulodandakami iti email iti aniaman a saludsod/singasing.']

How deadly is breast cancer?

Breast cancer is a serious and potentially deadly disease.

It is the most common cancer among women worldwide and the second leading cause of cancer death in women.

According to the American Cancer Society, in 20220, an estimated 276,480 new cases of invasive breast cancer were diagnosed in women in the United States, and about 42,170 women in the U.S. died from breast cancer.

However, the death rate from breast cancer has been declining since 1989, with a 40% decrease in the breast cancer death rate from 1989 to 2017, largely due to improvements in early detection and treatment.

The risk of dying from breast cancer varies depending on factors such as age, stage at diagnosis, and the type of breast cancer.

Early detection and treatment can significantly improve the chances of survival.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.

['Maipapan iti']

['Ti BioMedLib ket agusar kadagiti automatiko a computer (machine-learning algorithms) tapno makapataud kadagiti agassawa a saludsod ken sungbat.']

['Rugiantayo iti 35 a milion a publikasion ti biomedical iti PubMed/Medline. Kasta met, dagiti panid ti RefinedWeb.']

['Kitaenyo ti "References" ken "Disclaimer".']